logo
Select company
Select metric
$ 5.68EBITDA per Share
VS
Market
75
Sector
91
Industry
83
History
28
$ 59.44Close
$ 51.75 - $ 68.52 52-Week Range
Ticker Information

Ticker

UTMD

Company Name

UTAH MEDICAL PRODUCTS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

UTAH MEDICAL PRODUCTS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

UTMD - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ 18.44M$ 5.6813.25M
3/31/2025$ 18.75M$ 5.6613.31M
12/31/2024$ 19.65M$ 5.9913.28M
9/30/2024$ 21.36M$ 6.1413.48M
6/30/2024$ 23.01M$ 6.5113.53M
3/31/2024$ 25.05M$ 6.9313.62M
12/31/2023$ 26.46M$ 7.3713.59M
9/30/2023$ 27.74M$ 7.6413.63M
6/30/2023$ 28.26M$ 7.7913.63M
3/31/2023$ 28.29M$ 7.813.63M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UTAH MEDICAL PRODUCTS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 5.9.
  • Over the past 5 years, UTAH MEDICAL PRODUCTS INC's average EBITDAPS has been $ 6.79.
  • The median EBITDAPS for UTAH MEDICAL PRODUCTS INC during this period was $ 6.96
  • UTAH MEDICAL PRODUCTS INC reached its highest EBITDAPS over the past 5 years at $ 7.8.
  • The lowest EBITDAPS recorded by UTAH MEDICAL PRODUCTS INC in the same timeframe $ 5.66

UTAH MEDICAL PRODUCTS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
KRMD : KORU MEDICAL SYSTEMS INC $ -0.08STXS : STEREOTAXIS INC $ -0.25TLSI : TRISALUS LIFE SCIENCES INC $ -0.77EDIT : EDITAS MEDICINE INC $ -2.79CCCC : C4 THERAPEUTICS INC $ -1.45VYGR : VOYAGER THERAPEUTICS INC $ -1.72TKNO : ALPHA TEKNOVA INC $ -0.27MXCT : MAXCYTE INC $ -0.37RVP : RETRACTABLE TECHNOLOGIES INC $ -0.03PDEX : PRO DEX INC $ 4.3

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for UTAH MEDICAL PRODUCTS INC is calculated as follows: EBITDA [ $ 21.5M ] / (Shares WA [ 3.64M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 5.9 ]

UTMD - EBITDA per Share, Last 5 years

$ 5.66

Minimum

Mar 31, 2025

$ 7.8

Maximum

Mar 31, 2023

$ 6.79

Average

$ 6.96

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26